Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-24-018047

Chief Commercial Officer sold 3,108 shares at $90.00 ($279,720)

  • Chief Commercial Officer acquired 3,108 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-16 Exercise or conversion : show line 1 in the form 10b5-1 +1,144 $16.00 $18,304 15,519 D
2024-02-16 Exercise or conversion : show line 2 in the form 10b5-1 +1,714 $16.14 $27,664 17,233 D
2024-02-16 Sale : show line 3 in the form 10b5-1 −2,858 $90.00 $257,220 14,375 D
2024-02-20 Exercise or conversion : show line 4 in the form 10b5-1 +250 $16.14 $4,035 14,625 D
2024-02-20 Sale : show line 5 in the form 10b5-1 −250 $90.00 $22,500 14,375 D
Open-market sales · 3,108 sh · avg $90.00 · $279,720

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-02-16 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −1,144 0 D
2024-02-16 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −1,714 15,996 D
2024-02-20 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) −250 15,746 D
Loading xslF345X05/ownership.xml…